Drawing for IST INNUSCREEN

USPTO serial 79367451

IST INNUSCREEN

Reviewed by CopyMark Law Group

Reg. 7497769Status 700Registered
Filing date
Status date
Registration date
Sep 10, 2024
Examiner
GAGLIARDI, JEANINE
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with IST INNUSCREEN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Bradley M. Stohry

Bradley M. Stohry Reichel Stohry Dean LLP6151 Central AveIndianapolis, IN 46220United States

Goods and services

ClassDescriptionStatusFirst use
001Chemical analysis reagents being chemical reagents for non-medical purposes; chemical test reagents other than for medical or veterinary purposes; chemicals, namely, chemical test kits comprised of chemical solutions for the extraction, isolation and/or purification of DNA and RNA samples for laboratory or research use; chemicals for medical and biological research being chemical solutions and preparations consisting of pre-mixed reactants and reagents for scientific and research use in connection with extraction, and amplification, analysis, or labeling of nucleic acid; Reagents for diagnostic tests other than for medical or veterinary purposes, namely, chemical reagents for non-medical purposes; chemical reagents for amplification of nucleic acids other than for medical and veterinary purposes; chemicals for the amplification of nucleic acids being nucleic acid sequences other than for medical or veterinary purposes; chemicals for carrying out nucleic acid polymerase chain reactions other than for medical and veterinary use being chemical solutions and preparations consisting of premixed reactants and reagents for scientific and research use in connection with extraction and amplification, analysis, or labeling of nucleic acid; enzymes, other than for medical and veterinary purposes, namely, enzymes for scientific and research purposes; buffers being buffer solutions for use in analytical chemistry; the above-mentioned goods only for laboratory and research useACTIVE—
005Chemical test reagents being chemical reagents for medical purposes; chemical test reagents being chemical reagents for veterinary purposes; reagents for diagnostic tests, namely, chemical reagents for veterinary purposes; reagents for diagnostic tests being chemical reagents for medical purposes; reagents for the amplification of nucleic acids being chemical reagents for medical use; chemicals for the amplification of nucleic acids being chemical reagents for medical and veterinary use; chemicals for carrying out nucleic acid polymerase chain reactions being chemical reagents for medical and veterinary use; enzymes for medical purposes; enzymes for veterinary purposes; structural parts for all the aforesaid goods included in this classACTIVE—
007Machines for the manufacture of drugsACTIVE—
009Pressure sensors; measuring, signaling, checking, analyzing, controlling, regulating and recording apparatus and instruments, namely, measuring glassware, optical signaling cables, liquid analyzers, electronic controls for motors, control valves for regulating the flow of gases and liquids, and apparatus for recording data; Laboratory apparatus for extraction, isolation and purification of DNA and RNA samples; laboratory apparatus and instruments, namely, medical laboratory research instruments for DNA/RNA extraction; stored downloadable computer programs for DNA/RNA clean up; downloadable software for scientific measuring instruments for DNA/RNA clean up including binding, washing and elution steps; downloadable software for performing, evaluating and displaying chemical and biochemical analyses, processes and process controls; optical instruments for measuring and evaluating images being fiber optic light and image conduits; analytical and diagnostic equipment not for medical purposes, namely, data processors; chemical laboratory reactors, optical apparatus and instruments in the nature of optical inspection apparatus for the analysis and evaluation of microscopic structures, sample carriers, biochips and for lab on the chip applications; laboratory apparatus for the detection of genetic sequences; DNA chips; biochip for research or scientific purposes; microchips; chips in the nature of integrated circuits with microchannels, microchambers and/or microflow chambers; cell culture devices for laboratory use in the nature of cell culture dishes and tissue culture flasks; scientific instruments, namely, kits comprised of medical laboratory research instruments for DNA/RNA analysis as complete systems of specific consumables for diagnostic purposes, without instrument function, for the isolation of DNA/RNA, consisting essentially of cartridges, syringe bodies with associated plunger rods, a filtration device for desalting and enrichment of DNA/RNA from buffers; robot-controlled laboratory apparatus in the nature of research laboratory analyzers for analyzing samples in the nature of blood and other bodily fluids; structural parts and accessories for all the aforesaid goods, included in this classACTIVE—
010Electrophoresis apparatus of medical purposes; automatic laboratory instruments for medical diagnosis namely, medical instruments for diagnostic use, namely, medical diagnostic testing in the fields of qPCR, digital PCR, droplet PCR, RNA extraction, DNA extraction; medical instruments and apparatus for monitoring vital signs, blood properties, and respiratory events; analytical apparatus for medical purposes, namely, hematology analyzers for medical diagnostic use; diagnostic apparatus for medical purposes, namely, medical apparatus for diagnostic radiopharmaceutical use; diagnostic equipment in the nature of flow cytometers for medical diagnostic uses; incubators for laboratories for medical purposes, namely, incubators for medical purposes; apparatus for DNA and RNA analysis for medical purposes in the nature of medical diagnostic apparatus for testing DNA and RNA; kits for medical and veterinary diagnostic purposes comprised of sample preparation device for medical diagnostic uses, namely, for sample preparation, modification and manipulation of cells and for labelling, separation, isolation, purification, amplification, sequencing and/or analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid amplification; structural parts and accessories for all the aforesaid goods, included in this classACTIVE—
042Engineering services; design and development of measuring instruments and sensors; industrial analysis being scientific analysis and industrial research services in the field of qPCR, digital PCR, droplet PCR, DNA extraction, RNA extraction; development of microelectromechanical systemsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 26, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 4, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
Apr 4, 2025FIMPFINAL DISPOSITION PROCESSED—
Dec 10, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 10, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Sep 10, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 1, 2024GPNXNOTIFICATION PROCESSED BY IB—
Jun 25, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 25, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 11, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jun 11, 2024OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jun 5, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 21, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 15, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 15, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 15, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 19, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 7, 2023RFNTREFUSAL PROCESSED BY IB—
Oct 14, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Oct 14, 2023RFRRREFUSAL PROCESSED BY MPU—
Sep 15, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 14, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 6, 2023DOCKASSIGNED TO EXAMINER—
Apr 18, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 14, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 13, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance